Speaker illustration

Doctor Filipa Gerardo

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

Member of:

European Society of Cardiology
Heart Failure Association

Analyzing the economic ramifications of the broad implementation of generic prasugrel

Event: ESC Congress 2024

Topic: Health Economics

Session: Mapping cardiovascular health: risk factors, interventions, and geographic insights

Thumbnail

The ESC Grand Quiz Spectacular - case presenters

Event: ESC Congress 2024

Topic: European Society of Cardiology

Session: The ESC Grand Quiz Spectacular

Thumbnail

Unveiling the eligibility for screening of cardiac amyloidosis in a real world population

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular heart disease 4

Thumbnail

Single centre 3-year experience in intermittent levosimendan infusion

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 5

Thumbnail

Unlocking stability: predictors of clinical stability in patients undergoing intermittent levosimendan infusions for advanced heart failure

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in acute heart failure 12

Thumbnail

Patiromer in hyperkalemia management: real-world perspective for spironolactone-untreated patients

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in acute heart failure 8

Thumbnail

Predicting hospitalizations through post-discharge heart failure appointment: evaluating the FENNIX score's performance

Event: Heart Failure 2024

Topic: Biomarkers

Session: Acute heart failure - diagnostic methods 2

Thumbnail

Risk of bleeding in patients with atrial fibrillation: ARC-HBR outperforms HASBLED

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters in arrhythmias and device therapy 1

Thumbnail

Meta-analysis of 3-month vs 12-month dual anti-platelet therapy after percutaneous coronary intervention

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Optimal antithrombotic regimen after percutaneous coronary intervention in stable coronary artery disease

Thumbnail

Eligibility for acetazolamide in real-world acute heart failure patients

Event: Heart Failure 2023

Topic: Treatment

Session: Chronic heart failure - treatment 5

Thumbnail